Back to Agenda
Cultural Diversity
Session Chair(s)
Atsushi Tsukamoto, PhD, MSc
Corporate Officer, Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
In the global and complex pharmaceutical ecosystem that exists today, the information and expertize that you need may be spread out all over the world. This means you need to work effectively and efficiently with various external partners (for instance, big and small companies, academics, etc.). These partners may have different standards, priorities, and/or values. If well managed, this diversity creates further opportunities, including new ways of doing things, but it also brings some challenges. In this session, focusing mainly on the US and Japan (with additional comments related to Europe and Asia), we will identify common pitfalls and issues related with the above, and also discuss potential solutions, with an eye to seizing the highly diverse opportunities in drug development.
Learning Objective : Identify their own characteristics and preferences in communication and values; Discuss common pitfalls and issues in highly diverse situations; Acquire practical tools to manage cultural diversity .
Speaker(s)
Facilitator
Gareth Julian Monteath, PhD, MBA, MS
Link Global Solution Inc., Japan
Executive Director
Have an account?